Table 4.
Response of biomarkers of metabolic health to intervention
| Olive | Coconut | Supplement | Placebo | RM GLM ANCOVA (P) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| n 15 | n 15 | n 17 | n 16 | ||||||||
| Mean | se | Mean | se | Mean | se | Mean | se | Time | Treatment | Time × treatment | |
| TC | |||||||||||
| Baseline (mmol/l) | 4·7 | 0·2 | 4·9 | 0·2 | 5·6 | 0·2 | 5·2 | 0·2 | 0·90 | 0·17 | 0·53 |
| Post-intervention (mmol/l) | 4·8 | 0·3 | 5·1 | 0·3 | 5·3 | 0·2 | 5·3 | 0·3 | |||
| HDL-cholesterol | |||||||||||
| Baseline (mmol/l) | 1·6 | 0·1 | 1·5 | 0·1 | 1·7 | 0·1 | 1·7 | 0·1 | 0·10 | 0·75 | 0·46 |
| Post-intervention (mmol/l) | 1·6 | 0·1 | 1·6 | 0·1 | 1·7 | 0·1 | 1·7 | 0·1 | |||
| LDL-cholesterol | |||||||||||
| Baseline (mmol/l) | 2·6 | 0·2 | 2·8 | 0·2 | 3·3 | 0·2 | 2·9 | 0·2 | 0·69 | 0·38 | 0·48 |
| Post-intervention (mmol/l) | 2·7 | 0·2 | 2·9 | 0·2 | 3·1 | 0·2 | 3·0 | 0·2 | |||
| TAG | |||||||||||
| Baseline (mmol/l) | 1·1 | 0·2 | 1·4 | 0·2 | 1·2 | 0·2 | 1·3 | 0·2 | 0·47 | 0·63 | 0·79 |
| Post-intervention (mmol/l) | 1·0 | 0·2 | 1·4 | 0·2 | 1·3 | 0·1 | 1·2 | 0·1 | |||
| Glucose | |||||||||||
| Baseline (mmol/l) | 5·3 | 0·1 | 5·4 | 0·1 | 5·4 | 0·1 | 5·6 | 0·1 | 0·73 | 0·27 | 0·21 |
| Post-intervention (mmol/l) | 5·0 | 0·3 | 5·2 | 0·3 | 5·4 | 0·3 | 6·1 | 0·3 | |||
| CRP | |||||||||||
| Baseline (mg/dl) | 2·9 | 0·5 | 2·1 | 0·5 | 1·6 | 0·5 | 1·8 | 0·5 | 0·79 | 0·39 | 0·49 |
| Post-intervention (mg/dl) | 3·0 | 0·5 | 1·9 | 0·5 | 1·5 | 0·5 | 1·8 | 0·5 | |||
RM GLM ANCOVA, repeated-measures general linear model ANCOVA; TC, total cholesterol; CRP, C-reactive protein.
Data presented as mean ± standard error.
RM GLM ANCOVA was used to explore differences in biomarkers of metabolic health measures between groups.
P < 0·05 was considered statistically significant.